Stephen M Anderton Selected Research

Stephen M Anderton Research Topics

Disease

17	Inflammation (Inflammations) 01/2021 - 12/2004
15	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2015 - 11/2004
14	Autoimmune Diseases (Autoimmune Disease) 03/2014 - 11/2005
6	Neoplasms (Cancer) 12/2017 - 01/2008
6	Multiple Sclerosis 01/2013 - 07/2007
4	Hypersensitivity (Allergy) 01/2014 - 06/2010
3	Infections 01/2014 - 05/2006
2	Colitis 11/2018 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2017 - 09/2015
2	Asthma (Bronchial Asthma) 02/2014 - 03/2013
2	Eosinophilia 03/2013 - 06/2010
2	Arthritis (Polyarthritis) 08/2012 - 12/2011
2	Anaphylaxis (Anaphylactic Shock) 11/2011 - 12/2007
1	Pneumonia (Pneumonitis) 11/2018
1	Ulcerative Colitis 11/2018
1	Acute Lung Injury 11/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2018
1	Atopic Dermatitis (Atopic Eczema) 01/2018
1	Eczema 01/2018
1	Skin Diseases (Skin Disease) 01/2018
1	Allergic Contact Dermatitis 01/2018
1	Neoplasm Metastasis (Metastasis) 12/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Fibrosarcoma 09/2015
1	Reperfusion Injury 01/2015
1	Hepatitis 01/2015
1	Salmonella Infections (Salmonellosis) 03/2014
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2011
1	Experimental Arthritis 12/2011
1	Paralysis (Palsy) 06/2011
1	Demyelinating Diseases (Demyelinating Disease) 06/2011
1	Rheumatoid Arthritis 01/2010

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 05/2015 - 11/2004
6	AntigensIBA 09/2015 - 01/2007
6	AutoantigensIBA 10/2012 - 11/2005
5	CytokinesIBA 09/2015 - 10/2005
4	Dinoprostone (PGE2)FDA Link 01/2021 - 03/2016
4	LigandsIBA 09/2015 - 11/2004
4	EpitopesIBA 03/2013 - 12/2007
4	Myelin Basic ProteinIBA 01/2013 - 11/2004
3	Interleukin-22 (IL-22)IBA 11/2018 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 03/2014 - 06/2008
3	AllergensIBA 03/2013 - 06/2010
3	Interleukin-6 (Interleukin 6)IBA 02/2013 - 05/2012
3	Rituximab (Mabthera)FDA Link 05/2012 - 07/2007
3	Proteins (Proteins, Gene)FDA Link 11/2011 - 12/2004
2	InterleukinsIBA 11/2018 - 05/2012
2	ProstaglandinsIBA 01/2018 - 03/2016
2	ChemokinesIBA 09/2015 - 09/2008
2	Immunoglobulin M (IgM)IBA 01/2015 - 03/2014
2	Interleukin-10 (Interleukin 10)IBA 03/2014 - 09/2007
2	OvalbuminIBA 02/2014 - 03/2013
2	Interleukin-17 (Interleukin 17)IBA 11/2013 - 03/2009
2	Interleukin-5 (Interleukin 5)IBA 03/2013 - 06/2010
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 03/2013 - 03/2010
2	Immunoglobulin E (IgE)IBA 03/2013 - 11/2011
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2013 - 11/2005
2	AntibodiesIBA 11/2011 - 01/2008
2	Myelin-Oligodendrocyte GlycoproteinIBA 06/2011 - 03/2010
1	purineIBA 11/2018
1	HaptensIBA 01/2018
1	OxazoloneIBA 01/2018
1	IntegrinsIBA 01/2018
1	Chemokine CCL5IBA 12/2017
1	Interleukin-33IBA 12/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2017
1	Carboxylic Ester HydrolasesIBA 01/2017
1	LipidsIBA 01/2017
1	VLDL LipoproteinsIBA 01/2017
1	Methionine (L-Methionine)FDA Link 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Choline (Choline Chloride)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 09/2015
1	PND 1186IBA 09/2015
1	Interleukin-2 (IL2)IBA 09/2015
1	CarcinogensIBA 09/2015
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2015
1	Concanavalin AIBA 01/2015
1	Isoantigens (Alloantigen)IBA 01/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2013
1	Therapeutic UsesIBA 03/2013
1	Interleukin-13IBA 03/2013
1	Biological ProductsIBA 01/2013
1	Proteoglycans (Proteoglycan)IBA 08/2012
1	Chaperonin 60IBA 12/2011
1	Phosphates (Orthophosphate)IBA 12/2011
1	Freund's AdjuvantIBA 12/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2011
1	CD11c AntigenIBA 09/2010
1	Indicators and Reagents (Reagents)IBA 01/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2010

Therapy/Procedure

14	Therapeutics 11/2018 - 01/2007
9	Immunotherapy 01/2017 - 12/2007
1	Transplantation 01/2014
1	Organ Transplantation 01/2014
1	Ligation 10/2012
1	Intranasal Administration 12/2011
1	Mucosal Administration 12/2011